- Home
- AGFY vs MAIA Comparison
AGFY vs MAIA Comparison
Compare AGFY & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGFY
- MAIA
- Stock Information
- Founded
- AGFY 2016
- MAIA 2018
- Country
- AGFY United States
- MAIA United States
- Employees
- AGFY N/A
- MAIA N/A
- Industry
- AGFY Military/Government/Technical
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- AGFY Consumer Discretionary
- MAIA Health Care
- Exchange
- AGFY Nasdaq
- MAIA Nasdaq
- Market Cap
- AGFY 41.0M
- MAIA 47.7M
- IPO Year
- AGFY 2021
- MAIA 2022
- Fundamental
- Price
- AGFY $16.25
- MAIA $1.58
- Analyst Decision
- AGFY
- MAIA
- Analyst Count
- AGFY 0
- MAIA 0
- Target Price
- AGFY N/A
- MAIA N/A
- AVG Volume (30 Days)
- AGFY 21.6K
- MAIA 135.8K
- Earning Date
- AGFY 04-14-2025
- MAIA 03-24-2025
- Dividend Yield
- AGFY N/A
- MAIA N/A
- EPS Growth
- AGFY N/A
- MAIA N/A
- EPS
- AGFY N/A
- MAIA N/A
- Revenue
- AGFY $10,385,000.00
- MAIA N/A
- Revenue This Year
- AGFY $468.67
- MAIA N/A
- Revenue Next Year
- AGFY N/A
- MAIA N/A
- P/E Ratio
- AGFY N/A
- MAIA N/A
- Revenue Growth
- AGFY N/A
- MAIA N/A
- 52 Week Low
- AGFY $2.71
- MAIA $1.29
- 52 Week High
- AGFY $84.44
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- AGFY 39.53
- MAIA 36.89
- Support Level
- AGFY $14.42
- MAIA $1.46
- Resistance Level
- AGFY $19.21
- MAIA $1.63
- Average True Range (ATR)
- AGFY 2.05
- MAIA 0.14
- MACD
- AGFY -0.25
- MAIA -0.02
- Stochastic Oscillator
- AGFY 24.90
- MAIA 19.05
About AGFY Agrify Corporation
Agrify Corp is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Its proprietary micro-environment-controlled Agrify Vertical Farming Units (VFUs) enable cultivators to produce high-quality products The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.